Hledat v komentářích
Investiční doporučení
Výsledky společností - ČR
Výsledky společností - Svět
IPO, M&A
Týdenní přehledy
 

Detail - články

Richter, Egis: Pharmas oppose planned healthcare reform measures

23.8.2006 10:30
Autor: KBC/Patria

Hungarian pharmaceutical market participants oppose the planned healthcare reforms measures leaked out last week from a working draft of the convergence program–ac
Market players do not see feasible the introduction of cap on drug subsidies each individual can receive planned to be introduced from 2009-2010, as people's health is not static. Moreover, they see the validity of a limit on annual drug subsidies for individuals to be underlined also by the lack of similar practice elsewhere in the world. Pharma market players also see the extension of fixed subsidy system as problematic, since the monitoring of the drugs in the drug subsidy system is currently beyond the National Heath Fund's current capacity. Press also reports that the Government does not plan to negotiate with drug makers to renew the current agreement expiring at the end of 2006 on co-financing the gap of the drug subsidy budget with the drug makers.

Our view: We would se the current news as neutral to today's trading. Subsidy limitation plans of the government for 2009 are very soft at the moment, and it is very hard to predictit its impact on pharmas. The lack of a general agreement with pharmas on 2007, and the low (however, reportedly increasing) willingness of the government to start negotiations on that are slightly negative. Please note however, if no agreement is singed with the pharmas than they will not pay back any forint to the subsidy budget next year. This year drugmaker's contribution to the budget is expected at HUF 40bn, thus we beleive, the lack of could finally force National Health Fund/government to start talks.


Váš názor
Na tomto místě můžete zahájit diskusi. Zatím nebyl zadán žádný názor. Do diskuse mohou přispívat pouze přihlášení uživatelé (Přihlásit). Pokud nemáte účet, na který byste se mohli přihlásit, registrujte se zde.
Aktuální komentáře

Související komentáře
Nejčtenější zprávy dne
Nejčtenější zprávy týdne
Nejdiskutovanější zprávy týdne
Denní kalendář hlavních událostí
Nebyla nalezena žádná data